This clinical overview details the latest evidence-based strategies for diagnosing and treating symptoms of benign prostatic hyperplasia in men.
The global Benign Prostatic Hyperplasia Surgical Treatment Market size was valued at USD 2,042.94 million in 2024 and is expected to grow at a CAGR of 5.3% The aging male population's growing need for ...
The Five-item Frailty Index (5i-FI) is a tool used by physicians to predict surgical risk and postoperative complications after a procedure. Researchers from Brigham and Women's Hospital, a founding ...
The prospective, double-blind, randomized controlled trial (RCT) enrolled 244 patients to evaluate the Butterfly Prostatic Retraction Device, a minimally invasive, reversible implant that mechanically ...
Astute Analytica released an extensive market assessment report titled “Global Benign Prostatic Hyperplasia Surgical Treatment Market: Trends, Industry Competition Analysis, Revenue, and Forecast to ...
At University of Utah Health, our urologists specialize in helping men achieve better health with top-notch specialty care and the latest advances in treatment and therapies. We provide care for a ...
En-bloc and 2-lobe techniques may offer efficiency benefits but do not result in improvements in postoperative outcomes. (HealthDay News) — For patients undergoing Thulium laser enucleation of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results